We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Mor4.5
Moringa Research
Mostly mechanism / observational
45 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Moringa studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2010–2026 with a typical study size of 341 participants.
Based on 45 studies · 2 meta-analyses · 20 RCTs · 363 total participants
35 studies in the last 5 years · Latest meta-analysis: 2025
201020182026
1Review2025
In plain English: Together, Moringa oleifera could be considered for the treatment of conditions related to immune dysregulation, such as cancer.
Tilaoui M, El Karroumi J, Ait Mouse H, Zyad A. · International journal of molecular sciences (2025)
Furthermore, the immunomodulatory properties and possible application in health promotion and disease prevention, especially in cancer therapy, are discussed.
Studies indicate that Moringa oleifera can modulate the tumor microenvironment (TME) by reducing Treg polarization, enhancing NK cell cytotoxicity, and prompting the proliferation and clonal expansion of CD8 + and CD4 + T lymphocytes.
Together, Moringa oleifera could be considered for the treatment of conditions related to immune dysregulation, such as cancer.
In plain English: Hence, this review gives an overview of the potential health benefits linked to M. oleifera's isothiocyanates as a natural source of H 2 S.
Ponticelli M, Montanaro R, Calderone V, Vellecco V, Piragine E, Tzvetkov NT, Milella L, Martelli A, Brancaleone V. · Phytotherapy research : PTR (2026)
All articles containing information on the biological activity of M. oleifera's isothiocyanates were considered for selecting articles for analysis.
Review articles, letters, book chapters, editorials, conference papers, systematic reviews, and short surveys were not considered.
This allowed the selection of 42 papers, which were analyzed per pathologies and evaluated for the risk of biases using the QUIN tool.
In plain English: However, careful formulation optimization is crucial to minimize potential health risks and prevent undesirable sensory alterations in the final products.
Ramesh B, Chauhan R, Don PMU, Joshi R, Pansare S, Modi Z, Verma A, Abdur Rahim Imthiaz FR, Chaudhary P, Vashisht P, Modak B, Gandhi G, Rathnakumar K. · Journal of the science of food and agriculture (2026)
Moringa oleifera is a valuable source of protein, fiber, fats, vitamins, and minerals, and exhibits antimicrobial, antidiabetic, and antioxidant properties.
Furthermore, its inclusion in food products has been deemed safe and shown to enhance nutritional quality, functionality, and shelf life.
Different parts of M. oleifera have been identified as suitable for specific applications in the food sector.
In plain English: Further large-scale clinical studies and standardized safety assessments are essential before herbal neurotherapeutics can be widely applied in cognitive and neurological disorders.
Rahman M et al. · Nutrients (2026)
Medicinal herbs such as Bacopa monnieri, Withania somnifera, Ginkgo biloba, Glycyrrhiza glabra, Moringa oleifera, and ginseng have shown potential cognitive benefits in experimental models and selected human studies.
Advanced delivery systems, including nanoparticles and phytosomes, may further improve the bioavailability and brain-targeting efficiency of herbal compounds.
However, current clinical evidence remains heterogeneous and limited by insufficient standardization, small sample sizes, and short study durations.
In plain English: Further research is necessary to confirm these findings.
Samarin MM, Sheikhhossein F, Khalilkhaneh AH, Ghaemi S, Abbasi A, Bazyar H, Djafari F, Dianati Z, Khodashenas SM, Askari G, Amini MR. · Food science & nutrition (2026)
The results indicated that Moringa oleifera consumption significantly reduced systolic blood pressure (SBP) by weighted mean differences (WMDs): -6.00 mmHg, p < 0.001 and diastolic blood pressure (DBP) by WMD: -7.32 mmHg, p < 0.001.
However, no significant changes were observed in body mass index (BMI) ( p = 0.435) and body weight ( p = 0.938) compared to those who did not consume Moringa oleifera .
Subgroup analyses revealed that SBP significantly decreased in adults consuming 5-10 g/day of Moringa oleifera , particularly in individuals with a BMI below 29.9 and those treated for more than 4 weeks.
In plain English: To improve the current contests and the scalability and suitability of moringa-based functional foods, this review concludes with a call for additional investigation.
Arshad MT, Maqsood S, Ikram A, Gnedeka KT. · Food science & nutrition (2025)
Investigation into the usage of moringa products in functional foods like dairy substitutes, powders, supplements, drinks, and even snacks is also part of the review.
Notwithstanding the auspicious benefits, there are also contests with product development such as issues with sensory perception, active ingredient constancy, and budget constraints.
Maintainable plant-based and healthy food demand across the sphere is pushing the novelty in the moringa industry.
In plain English: Further large-scale, rigorously designed RCTs are warranted to clarify its therapeutic potential and optimal supplementation parameters.
Crișan D, Gavrilaș L, Păltinean R, Frumuzachi O, Mocan A, Crișan G. · Nutrients (2025)
A modest reduction in diastolic blood pressure (SMD: -0.41; 95% CI: -0.75 to -0.07; p = 0.02; I 2 = 19%) was observed; however, this effect was not robust in sensitivity analyses.
Nevertheless, risk of bias, substantial heterogeneity ( I 2 frequently >80% for anthropometric and lipid parameters), indirectness, and methodological limitations reduced the overall certainty of evidence to very low for all the evaluated outcomes.
Subgroup analyses suggested potential benefits at doses <10 g/day, in participants <50 years old, and in interventions lasting ≥12 weeks.